Package 68001-492-36

Brand: doxorubicin hydrochloride

Generic: doxorubicin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 68001-492-36
Digits Only 6800149236
Product NDC 68001-492
Product ID 68001-492_37f332f8-cf9b-200e-e063-6294a90af021
Description

1 VIAL, SINGLE-DOSE in 1 PACKAGE (68001-492-36) / 10 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2021-05-31
Brand doxorubicin hydrochloride
Generic doxorubicin hydrochloride
Sample Package No

Linked Drug Pages (1)

Doxorubicin Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "37f332f8-cf9b-200e-e063-6294a90af021", "openfda": {"upc": ["0368001493260", "0368001492362"], "unii": ["82F2G7BL4E"], "rxcui": ["1790115", "1790127"], "spl_set_id": ["f6508535-e7a7-4e50-8d0c-43deda8d0d08"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 PACKAGE (68001-492-36)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "68001-492-36", "marketing_start_date": "20210531"}], "brand_name": "Doxorubicin Hydrochloride", "product_id": "68001-492_37f332f8-cf9b-200e-e063-6294a90af021", "dosage_form": "INJECTABLE, LIPOSOMAL", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "68001-492", "generic_name": "Doxorubicin Hydrochloride", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxorubicin Hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA203263", "marketing_category": "ANDA", "marketing_start_date": "20210531", "listing_expiration_date": "20261231"}